These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Sachar DB; Taub RN; Ramachandar K; Meyers S; Forman SP; Douglas SD; Janowitz HD Ann N Y Acad Sci; 1976; 278():565-73. PubMed ID: 1085595 [No Abstract] [Full Text] [Related]
3. Lymphocyte subpopulations in Crohn's disease and chronic ulcerative colitis. Sorensen SF; Hoj L Acta Pathol Microbiol Scand C; 1977 Feb; 85(1):41-8. PubMed ID: 320824 [TBL] [Abstract][Full Text] [Related]
4. [Abnormal humoral and cellular immunity in ulcerative colitis and Crohn's disease]. Asakura H; Tanaka T; Hibi T; Miura S; Mizuno Y; Oda Y; Tsuchiya M Nihon Rinsho; 1977 May; 35(5):1828-35. PubMed ID: 301952 [No Abstract] [Full Text] [Related]
9. Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon. Baklien K; Brandtzaeg P Clin Exp Immunol; 1975 Nov; 22(2):197-209. PubMed ID: 1082398 [TBL] [Abstract][Full Text] [Related]
12. [Immunologic studies in patients with Crohn disease and ulcerative colitis]. Sauer H; Sauer D; Bendix U; Schumann B Allerg Immunol (Leipz); 1984; 30(1):23-33. PubMed ID: 6203390 [TBL] [Abstract][Full Text] [Related]
13. Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine. Campbell AC; Skinner JM; Hersey P; Roberts-Thomson P; MacLennan IC; Truelove SC Clin Exp Immunol; 1974 Apr; 16(4):521-33. PubMed ID: 4468852 [TBL] [Abstract][Full Text] [Related]
14. Blood transfusion, skin test reactivity, and lymphocytes in inflammatory bowel disease. Tartter PI; Heimann TM; Aufses AH Am J Surg; 1986 Mar; 151(3):358-61. PubMed ID: 3485387 [TBL] [Abstract][Full Text] [Related]
15. The subpopulations of circulating white blood cells in inflammatory bowel disease. Thayer WR; Charland C; Field CE Gastroenterology; 1976 Sep; 71(3):379-84. PubMed ID: 1084844 [TBL] [Abstract][Full Text] [Related]
16. T-cell immunoregulation in patients with inflammatory bowel disease. II. Enhanced suppressor T-cell activity in ulcerative colitis. Kramer JK; Depew WT; Szewczuk MR J Clin Lab Immunol; 1988 Jan; 25(1):19-27. PubMed ID: 2968458 [TBL] [Abstract][Full Text] [Related]
17. Serum lymphocytotoxic and lymphocytophilic antibody activity in inflammatory bowel disease. Korsmeyer S; Strickland RG; Wilson ID; Williams RC Gastroenterology; 1974 Oct; 67(4):578-83. PubMed ID: 4607065 [No Abstract] [Full Text] [Related]
18. Pokeweed mitogen stimulated immunoglobulin production by peripheral blood lymphocytes in vitro: evidence for disordered immunoregulation in patients with ulcerative colitis and Crohn's disease. Danis VA; Heatley RV Clin Exp Immunol; 1983 Dec; 54(3):739-46. PubMed ID: 6606515 [TBL] [Abstract][Full Text] [Related]
19. [The pathogenesis of inflammatory bowel disease viewed from immunological aspects]. Hibi T; Inoue N Nihon Shokakibyo Gakkai Zasshi; 2001 Apr; 98(4):390-8. PubMed ID: 11400268 [No Abstract] [Full Text] [Related]
20. T-cell immunoregulation in patients with inflammatory bowel disease. I. Differential helper T-cell function in ulcerative colitis and Crohn's disease. Kramer JK; Depew WT; Szewczuk MR J Clin Lab Immunol; 1988 Jan; 25(1):9-17. PubMed ID: 2968459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]